Topical Immunotherapy with Diphenylcyclopropenone in Pediatric Patients with Alopecia Areata: A Retrospective Study of 97 Patients
August 2024
in “
Skin Health and Disease
”
Studysummary Among pediatric alopecia areata patients treated with DPCP, this study reported complete hair regrowth in 8.8% and any regrowth in 61.8% after one year, with better outcomes for those with milder initial symptoms and longer treatment durations.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →